Figure 2: Proposed Clinical Algorithm for Primary Prevention of Cardiovascular Disease in Patients with Clonal Hematopoiesis.
We propose the following pathway for management of individuals with CHIP. We lack an evidence base for such recommendations, as recognition of the relationship between CHIP and cardiovascular disease has only recently become apparent. Yet, clinicians must be able to offer assistance and counseling to CHIP carriers while building a body of evidence.